A case report of parenchymal hematoma after intravenous thrombolysis in a rivaroxaban-treated patient: Is it a true rivaroxaban hemorrhagic complication?

RATIONALE: To date, the only treatment approved for acute ischemic strokes is thrombolysis. Whether intravenous thrombolysis may be safe in patients taking direct oral anticoagulants (DOACs) is currently a matter of debate. PATIENT CONCERNS: A 74-year-old woman, who was on rivaroxaban 20 mg/d for no...

Descripción completa

Detalles Bibliográficos
Autores principales: Rota, Eugenia, Bruzzone, Gianluca, Agosti, Sergio, Pastorino, Roberto, Morelli, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758276/
https://www.ncbi.nlm.nih.gov/pubmed/29390574
http://dx.doi.org/10.1097/MD.0000000000009435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758276/
https://www.ncbi.nlm.nih.gov/pubmed/29390574
http://dx.doi.org/10.1097/MD.0000000000009435

Ejemplares similares